Nakatsu, Japan

Yoshifumi Ikeda

This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Hassle. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshifumi Ikeda. Retrieved from https://idiyas.com/inventor/yoshifumi-ikeda-txmd87cl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshifumi Ikeda

Introduction

Yoshifumi Ikeda is a notable inventor based in Nakatsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative use of omeprazole as an antimicrobial agent. His work has garnered attention for its potential applications in medical treatments.

Latest Patents

Yoshifumi Ikeda holds 1 patent for his invention related to the use of omeprazole. This patent highlights his expertise in leveraging existing compounds for new therapeutic purposes, showcasing his innovative approach to problem-solving in the medical field.

Career Highlights

Ikeda is currently employed at Aktiebolaget Hassle, a company known for its focus on pharmaceutical advancements. His role there allows him to further explore and develop his ideas, contributing to the company's mission of improving health outcomes through innovative solutions.

Collaborations

Throughout his career, Yoshifumi Ikeda has collaborated with talented individuals such as Masaaki Tomoi and Yoshiko Yokota. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Yoshifumi Ikeda's contributions to the field of pharmaceuticals, particularly through his patent on omeprazole, demonstrate his innovative spirit and commitment to advancing medical science. His work continues to inspire and pave the way for future developments in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…